|Articles|September 24, 2010

Medical Economics, Digital Edition, September 24th, 2010

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Medical Economics, Digital Edition, September 24th, 2010

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

Primary care cuts the financial and human cost of chronic disease. So why isn’t the nation investing in it?

McKesson data breach exposes prescribing physicians and their patients to fallout from a third-party attack

Lifestyle medicine could be direct primary care's next differentiator, whitepaper says

Kennedy asks the public to weigh in on the AMA's control of codes by Sept. 14

What physicians can actually do about a fake or defamatory online review